To know the scope of our report Get a Sample on Regulatory Affairs Outsourcing Market
Get a glimpse of the in-depth analysis through our Report Brochure
Expanding operations in the future? To get the perfect launch to ask for a custom report
Attribute |
Detail |
Market Size Value in 2020 |
US$ 4.5 Bn |
Market Forecast Value in 2028 |
US$ 17.3 Bn |
Growth Rate (CAGR) |
19% |
Forecast Period |
2021–2028 |
Quantitative Units |
US$ Mn for Value |
Market Analysis |
It includes cross segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
Competition Landscape |
|
Format |
Electronic (PDF) + Excel |
Market Segmentation |
|
Regions Covered |
|
Countries Covered |
|
Companies Profiled |
|
Customization Scope |
Available upon request |
Pricing |
Available upon request |
Regulatory Affairs Outsourcing Market – Segmentation
Service |
|
Region |
|
The global market for regulatory affairs outsourcing was worth US$ 4.5 Bn and is projected to reach a value of US$ 17.3 Bn by the end of 2028
The market for regulatory affairs outsourcing is anticipated to grow at a CAGR of 19% during the forecast period
North America accounted for a major share of the global market
Regulatory affairs outsourcing market is driven by increase in the number of clinical trials, growth of the life sciences industry, and advancements in biosimilars, personalized medicine, orphan pharmaceuticals
Key players in the global market for regulatory affairs outsourcing include Accell Clinical Research, LLC, Charles River Laboratories International, Inc., Clinilabs, Inc., Covance, Inc., Criterium, Inc., ICON plc, Medpace, Inc., PAREXEL International Corporation, Pharmaceutical Product Development, (PPD) LLC, Promedica International, Quintiles Transnational Corporation, and WuXi App Tec.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Regulatory Affairs Outsourcing Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Regulatory Affairs Outsourcing Market Analysis and Forecast, 2017–2028
5. Key Insights
5.1. Top 3 players operating in the market space
5.2. Regulatory Scenario by Region/globally
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemics Impact on Industry
6. Global Regulatory Affairs Outsourcing Market Analysis and Forecast, by Services
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Services, 2017–2028
6.3.1. Regulatory Affairs
6.3.2. Clinical Trial Applications & Product Registrations
6.3.3. Regulatory Writing & Publishing
6.3.4. Regulatory Consulting & Legal Representation
6.3.5. Others
6.4. Market Attractiveness By Services
7. Global Regulatory Affairs Outsourcing Market Analysis and Forecast, by Region
7.1. Key Findings
7.2. Market Value Forecast, by Region
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. Middle East & Africa
7.3. Market Attractiveness Analysis, by Region
8. North America Regulatory Affairs Outsourcing Market Analysis and Forecast
8.1. Introduction
8.1.1. Key Findings
8.2. Market Value Forecast, by Services, 2017–2028
8.2.1. Regulatory Affairs
8.2.2. Clinical Trial Applications & Product Registrations
8.2.3. Regulatory Writing & Publishing
8.2.4. Regulatory Consulting & Legal Representation
8.2.5. Others
8.3. Market Value Forecast, by Country, 2017–2028
8.3.1. U.S.
8.3.2. Canada
8.4. Market Attractiveness Analysis
8.4.1. By Services
8.4.2. By Country
9. Europe Regulatory Affairs Outsourcing Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Services, 2017–2028
9.2.1. Regulatory Affairs
9.2.2. Clinical Trial Applications & Product Registrations
9.2.3. Regulatory Writing & Publishing
9.2.4. Regulatory Consulting & Legal Representation
9.2.5. Others
9.3. Market Value Forecast, by Country/Sub-region, 2017–2028
9.3.1. Germany
9.3.2. U.K.
9.3.3. France
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Market Attractiveness Analysis
9.4.1. By Services
9.4.2. By Country/Sub-region
10. Asia Pacific Regulatory Affairs Outsourcing Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Services, 2017–2028
10.2.1. Regulatory Affairs
10.2.2. Clinical Trial Applications & Product Registrations
10.2.3. Regulatory Writing & Publishing
10.2.4. Regulatory Consulting & Legal Representation
10.2.5. Others
10.3. Market Value Forecast, by Country/Sub-region, 2017–2028
10.3.1. China
10.3.2. Japan
10.3.3. India
10.3.4. Australia & New Zealand
10.3.5. Rest of Asia Pacific
10.4. Market Attractiveness Analysis
10.4.1. By Services
10.4.2. By Country/Sub-region
11. Latin America Regulatory Affairs Outsourcing Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Services, 2017–2028
11.2.1. Regulatory Affairs
11.2.2. Clinical Trial Applications & Product Registrations
11.2.3. Regulatory Writing & Publishing
11.2.4. Regulatory Consulting & Legal Representation
11.2.5. Others
11.3. Market Value Forecast, by Country/Sub-region, 2017–2028
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of Latin America
11.4. Market Attractiveness Analysis
11.4.1. By Services
11.4.2. By Country/Sub-region
12. Middle East & Africa Regulatory Affairs Outsourcing Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Services, 2017–2028
12.2.1. Regulatory Affairs
12.2.2. Clinical Trial Applications & Product Registrations
12.2.3. Regulatory Writing & Publishing
12.2.4. Regulatory Consulting & Legal Representation
12.2.5. Others
12.3. Market Value Forecast, by Country/Sub-region, 2017–2028
12.3.1. GCC Countries
12.3.2. South Africa
12.3.3. Rest of Middle East & Africa
12.4. Market Attractiveness Analysis
12.4.1. By Services
12.4.2. By Country/Sub-region
13. Competition Landscape
13.1. Market Player - Competition Matrix (by tier and size of companies)
13.2. Market Share Analysis, by Company, 2020
13.3. Company Profiles
13.3.1. Accell Clinical Research, LLC
13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.1.2. Financial Analysis
13.3.1.3. Growth Strategies
13.3.1.4. SWOT Analysis
13.3.2. Charles River Laboratories International, Inc.
13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.2.2. Financial Analysis
13.3.2.3. Growth Strategies
13.3.2.4. SWOT Analysis
13.3.3. Clinilabs, Inc.
13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.3.2. Financial Analysis
13.3.3.3. Growth Strategies
13.3.3.4. SWOT Analysis
13.3.4. Covance, Inc.
13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.4.2. Financial Analysis
13.3.4.3. Growth Strategies
13.3.4.4. SWOT Analysis
13.3.5. Criterium, Inc.
13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.5.2. Financial Analysis
13.3.5.3. Growth Strategies
13.3.5.4. SWOT Analysis
13.3.6. ICON plc.
13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.6.2. Financial Analysis
13.3.6.3. Growth Strategies
13.3.6.4. SWOT Analysis
13.3.7. Medpace, Inc.
13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.7.2. Financial Analysis
13.3.7.3. Growth Strategies
13.3.7.4. SWOT Analysis
13.3.8. PAREXEL International Corporation
13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.8.2. Financial Analysis
13.3.8.3. Growth Strategies
13.3.8.4. SWOT Analysis
13.3.9. Pharmaceutical Product Development, (PPD) LLC
13.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.9.2. Financial Analysis
13.3.9.3. Growth Strategies
13.3.9.4. SWOT Analysis
13.3.10. Quintiles Transnational Corporation
13.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.10.2. Financial Analysis
13.3.10.3. Growth Strategies
13.3.10.4. SWOT Analysis
13.3.11. WuXi App Tec
13.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.11.2. Financial Analysis
13.3.11.3. Growth Strategies
13.3.11.4. SWOT Analysis
List of Tables
Table 1: Market Snapshot: Global Regulatory Affairs Outsourcing Market, 2017 and 2028
Table 2: Percentage of Registered Studies by Location
Table 3: Share of Total Global R&D Spending
Table 4: Global Regulatory Affairs Outsourcing Market Revenue (US$ Mn), by Services, 2021–2028
Table 5: Global Regulatory Affairs Outsourcing Market Revenue (US$ Mn), by Region, 2021–2028
Table 6: North America Regulatory Affairs Outsourcing Market Revenue (US$ Mn), by Country, 2021–2028
Table 7: Europe Regulatory Affairs Outsourcing Market Revenue (US$ Mn), by Country/Sub-region, 2021–2028
Table 8: Asia Pacific Regulatory Affairs Outsourcing Market Revenue (US$ Mn), by Country/Sub-region, 2021–2028
Table 9: Latin America Regulatory Affairs Outsourcing Market Revenue (US$ Mn), by Country/Sub-region, 2021–2028
Table 10: Middle East and Africa Regulatory Affairs Outsourcing Market Revenue (US$ Mn), by Country/Sub-region, 2021–2028
List of Figures
Figure 1: Market Segmentation: Regulatory Affairs Outsourcing Market
Figure 2: Global Regulatory Affairs Outsourcing Market Share, by Region, 2017 and 2028 (Value %)
Figure 3: Global Regulatory Affairs Outsourcing Market (US$ Mn), by Services, 2017 and 2028 (Value %)
Figure 4: Porter’s Five Forces Analysis: Regulatory Affairs Outsourcing Market
Figure 5: Value Chain Analysis: Regulatory Affairs Outsourcing Market
Figure 6: Market Attractiveness Analysis: Regulatory Affairs Outsourcing Market
Figure 7: Competitive Landscape: Regulatory Affairs Outsourcing Market
Figure 8: Global Outsourcing of Regulatory Submissions Market Revenue (US$ Mn), 2021–2028
Figure 9: Global Outsourcing of Clinical Trial Application & Product Registration Market Revenue (US$ Mn), 2021–2028
Figure 10: Global Outsourcing of Regulatory Writing and Publishing Market Revenue (US$ Mn), 2021–2028
Figure 11: Global Outsourcing of Regulatory Consulting & Legal Representation Market Revenue (US$ Mn), 2021–2028
Figure 12: Global Outsourcing of Other Regulatory Affairs Services Market Revenue (US$ Mn), 2021–2028